California State Teachers Retirement System (CalSTRS)’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.82M	Buy	101,232 +23,109	+30%	+$1.22M	0.01%	1040
2025 Q4	$4.1M	Buy	78,123 +3,212	+4%	+$192K	﹤0.01%	1027
2025 Q3	$4.85M	Buy	74,911 +4	+0%	+$230	0.01%	951
2025 Q2	$3.64M	Buy	74,907 +5,165	+7%	+$200K	﹤0.01%	1056
2025 Q1	$2.37M	Hold	69,742	–	–	﹤0.01%	1242
2024 Q4	$2.75M	Sell	69,742 -689	-1%	-$32.5K	﹤0.01%	1216
2024 Q3	$3.31M	Sell	70,431 -2,472	-3%	-$125K	﹤0.01%	1116
2024 Q2	$3.94M	Buy	72,903 +5,002	+7%	+$289K	﹤0.01%	994
2024 Q1	$4.63M	Buy	67,901 +710	+1%	+$50.8K	0.01%	957
2023 Q4	$4.21M	Buy	67,191 +883	+1%	+$48.8K	0.01%	1008
2023 Q3	$3.01M	Buy	66,308 +564	+0.9%	+$29.1K	﹤0.01%	1149
2023 Q2	$3.69M	Buy	65,744 +403	+0.6%	+$22.9K	0.01%	1134
2023 Q1	$2.96M	Buy	65,341 +860	+1%	+$41.8K	﹤0.01%	1258
2022 Q4	$2.62M	Buy	64,481 +1,169	+2%	+$62K	﹤0.01%	1319
2022 Q3	$4.14M	Buy	63,312 +566	+0.9%	+$41K	0.01%	1014
2022 Q2	$3.81M	Buy	62,746 +10,698	+21%	+$629K	0.01%	1108
2022 Q1	$3.27M	Buy	52,048 +462	+0.9%	+$29K	﹤0.01%	1312
2021 Q4	$3.91M	Buy	51,586 +1,966	+4%	+$172K	﹤0.01%	1313
2021 Q3	$5.55M	Buy	+49,620	New	+$6.23M	0.01%	1080